References
- Sosa V, Moline T, Somoza R, Paciucci R, Kondoh H, ME LL. Oxidative stress and cancer: an overview. Ageing Res Rev. 2013; 12:376–90.10.1016/j.arr.2012.10.00423123177
- Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013; 12:931–47.2428778110.1038/nrd4002
- Gupta R, Sikka SC. Prostate cancer and oxidative stress. In: Laher I, editor. Systems biology of free radicals and antioxidants. Berlin: Springer-Verlag; 2014. p. 2835–50.
- Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer. 2007; 121:2381–6.1789386810.1002/ijc.23192
- Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011; 11:85–95.10.1038/nrc298121258394
- Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009; 458:780–3.10.1038/nature0773319194462
- Hecht F, Pessoa CF, Gentile LB, Rosenthal D, Carvalho DP, Fortunato RS. The role of oxidative stress on breast cancer development and therapy. Tumour Biol. 2016; 37:4281–91.10.1007/s13277-016-4873-9
- Hernandes MS, Troncone LRP. Glycine as a neurotransmitter in the forebrain: a short review. J Neural Transm (Vienna). 2009; 116:1551–60.10.1007/s00702-009-0326-6
- Leanza L, Zoratti M, Gulbins E, Szabo I. Mitochondrial ion channels as oncological targets. Oncogene. 2014; 33:5569–81.10.1038/onc.2013.57824469031
- Villalonga N, Ferreres JC, Argilés JM, Condom E, Felipe A. Potassium channels are a new target field in anticancer drug design. Recent Pat Anticancer Drug Discov. 2007; 2:212–23.1822106410.2174/157489207782497181
- Leanza L, Managò A, Zoratti M, Gulbins E, Szabo I. Pharmacological targeting of ion channels for cancer therapy: In vivo evidences. Biochim Biophys Acta. 2016; 1863:1385–97.2665864210.1016/j.bbamcr.2015.11.032
- Urrego D, Tomczak AP, Zahed F, Stühmer W, Pardo LA. Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci. 2014; 369:20130094, 10.1098/rstb.2013.0094.24493742
- Jang SH, Choi SY, Ryu PD, Lee SY. Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. Eur J Pharmacol. 2011; 651:26–32.2108760210.1016/j.ejphar.2010.10.066
- Borowiec AS, Hague F, Harir N, Guénin S, Guerineau F, Gouilleux F, et al. IGF-1 activates hEAG K+ channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation. J Cell Physiol. 2007; 212:690–701.10.1002/jcp.2106517520698
- Brevet M, Ahidouch A, Sevestre H, Merviel P, El Hiani Y, Robbe M, et al. Expression of K+ channels in normal and cancerous human breast. Histol Histopathol. 2008; 23:965–72.18498071
- So EC, Huang Y-M, Hsing C-H, Liao Y-K, Wu S-N. Arecoline inhibits intermediate-conductance calcium-activated potassium channels in human glioblastoma cell lines. Eur J Pharmacol. 2015; 758:177–87.2584341410.1016/j.ejphar.2015.03.065
- Leanza L, Venturini E, Kadow S, Carpinteiro A, Gulbins E, Becker KA. Targeting a mitochondrial potassium channel to fight cancer. Cell Calcium. 2015; 58:131–8.10.1016/j.ceca.2014.09.00625443654
- Hu L, Pennington M, Jiang Q, Whartenby KA, Calabresi PA. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes. J Immunol. 2007; 179:4563–70.10.4049/jimmunol.179.7.456317878353
- García-Quiroz J, Camacho J. Astemizole: an old anti-histamine as a new promising anti-cancer drug. Anticancer Agents Med Chem. 2011; 11:307–14.2144350410.2174/187152011795347513
- Kim Y, Kim WJ, Cha EJ. Quercetin-induced growth inhibition in human bladder cancer cells is associated with an increase in Ca2+-activated K+ channels. Korean J Physiol Pharmacol. 2011; 15:279–83.10.4196/kjpp.2011.15.5.279
- Jang SH, Kang KS, Ryu PD, Lee SY. Kv1.3 voltage-gated K+ channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. BMB Rep. 2009; 42:535–9.1971259210.5483/BMBRep.2009.42.8.535
- Chin LS, Park CC, Zitnay KM, Sinha M, DiPatri AJ Jr., Perillán P, et al. 4-Aminopyridine causes apoptosis and blocks an outward rectifier K+ channel in malignant astrocytoma cell lines. J Neurosci Res. 1997; 48:122–7.10.1002/(SICI)1097-4547(19970415)48:2<;122::AID-JNR4>3.0.CO;2-E9130140
- Ru Q, Tian X, Wu YX, Wu RH, Pi MS, Li CY. Voltage-gated and ATP-sensitive K+ channels are associated with cell proliferation and tumorigenesis of human glioma. Oncol Rep. 2014; 31:842–8.10.3892/or.2013.287524284968
- Liu J, Feng S, Zhang L, Wu Z, Chen Q, Cheng W, et al. [Expression and properties of potassium channels in human mammary epithelial cell line MCF10A and its possible role in proliferation]. Sheng Li Xue Bao [Acta Physiologica Sinica]. 2010; 62:203–9. [in Chinese, English abstract].20571736
- Leanza L, Henry B, Sassi N, Zoratti M, Chandy KG, Gulbins E, et al. Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol Med. 2012; 4:577–93.2249611710.1002/emmm.201200235
- de Guadalupe Chávez-Lòpez M, Hernández-Gallegos E, Vázquez-Sánchez AY, Gariglio P, Camacho J. Antiproliferative and proapoptotic effects of astemizole on cervical cancer cells. Int J Gynecol Cancer. 2014; 24:824–8.10.1097/IGC.000000000000015124819656
- Ouadid-Ahidouch H, Le Bourhis X, Roudbaraki M, Toillon RA, Delcourt P, Prevarskaya N. Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h.ether-á-gogo K+ channel. Receptors Channels. 2001; 7:345–56.
- Breier A, Gibalova L, Seres M, Barancik M, Sulova Z. New insight into p-glycoprotein as a drug target. Anticancer Agents Med Chem. 2013; 13:159–70.2293141310.2174/187152013804487380
- Jahchan NS, Dudley JT, Mazur PK, Flores N, Yang D, Palmerton A, et al. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov. 2013; 3:1364–77.10.1158/2159-8290.CD-13-018324078773
- García-Quiroz J, García-Becerra R, Santos-Martínez N, Barrera D, Ordaz-Rosado D, Avila E, et al. In vivo dual targeting of the oncogenic Ether-á-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors. BMC Cancer. 2014; 14:745, 10.1186/1471-2407-14-745.25280486
- Venturini E. Kv1.3 inhibitors in the treatment of glioma and melanoma [doctoral dissertation]. Germany: Universität Duisburg-Essen; 2015.
- Stone JR, Yang S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal. 2006; 8:243–70.10.1089/ars.2006.8.24316677071
- Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002; 165:934–9.1193471710.1164/ajrccm.165.7.2104126
- Chattopadhyay MK, Tabor CW, Tabor H. Polyamine deficiency leads to accumulation of reactive oxygen species in a spe2Δ mutant of Saccharomyces cerevisiae. Yeast. 2006; 23:751–61.10.1002/yea.1393
- Hermann A, Sitdikova GF, Weiger TM. Oxidative stress and maxi calcium-activated potassium (BK) channels. Biomolecules. 2015; 5:1870–911.10.3390/biom503187026287261
- Agostinelli E, Tempera G, Viceconte N, Saccoccio S, Battaglia V, Grancara S, et al. Potential anticancer application of polyamine oxidation products formed by amine oxidase: a new therapeutic approach. Amino Acids. 2010; 38:353–68.10.1007/s00726-009-0431-820012114
- Szabó I, Bock J, Grassmé H, Soddemann M, Wilker B, Lang F, et al. Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc Natl Acad Sci U S A. 2008; 105:14861–6.1881830410.1073/pnas.0804236105
- Jakhar R, Paul S, Bhardwaj M, Kang SC. Astemizole-Histamine induces Beclin-1-independent autophagy by targeting p53-dependent crosstalk between autophagy and apoptosis. Cancer Lett. 2016; 372:89–100.2673906110.1016/j.canlet.2015.12.024
- Woodfork KA, Wonderlin WF, Peterson VA, Strobl JS. Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture. J Cell Physiol. 1995; 162:163–71.782242710.1002/jcp.1041620202
- Ouadid-Ahidouch H, Roudbaraki M, Delcourt P, Ahidouch A, Joury N, Prevarskaya N. Functional and molecular identification of intermediate-conductance Ca2+-activated K+ channels in breast cancer cells: association with cell cycle progression. Am J Physiol Cell Physiol. 2004; 287:C125–34.1498523710.1152/ajpcell.00488.2003
- Zhang P, Yang X, Yin Q, Yi J, Shen W, Zhao L, et al. Inhibition of SK4 potassium channels suppresses cell proliferation, migration and the epithelial–mesenchymal transition in triple-negative breast cancer cells. PLoS One. 2016; 11:e0154471, 10.1371/journal.pone.0154471.27124117